nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CALM3—eye—Graves' disease	0.0185	0.0636	CbGeAlD
Phenoxybenzamine—SLC22A3—connective tissue—Graves' disease	0.0165	0.0567	CbGeAlD
Phenoxybenzamine—CALM2—eye—Graves' disease	0.0146	0.05	CbGeAlD
Phenoxybenzamine—CALM1—eye—Graves' disease	0.0145	0.0497	CbGeAlD
Phenoxybenzamine—CALM2—connective tissue—Graves' disease	0.014	0.0481	CbGeAlD
Phenoxybenzamine—CALM1—connective tissue—Graves' disease	0.014	0.0479	CbGeAlD
Phenoxybenzamine—CALM3—pituitary gland—Graves' disease	0.0138	0.0472	CbGeAlD
Phenoxybenzamine—CALM3—adipose tissue—Graves' disease	0.0137	0.047	CbGeAlD
Phenoxybenzamine—SLC22A1—adipose tissue—Graves' disease	0.0133	0.0455	CbGeAlD
Phenoxybenzamine—SLC22A3—adipose tissue—Graves' disease	0.0127	0.0435	CbGeAlD
Phenoxybenzamine—CALM3—thyroid gland—Graves' disease	0.0119	0.0407	CbGeAlD
Phenoxybenzamine—SLC22A3—thyroid gland—Graves' disease	0.011	0.0376	CbGeAlD
Phenoxybenzamine—CALM2—pituitary gland—Graves' disease	0.0108	0.0371	CbGeAlD
Phenoxybenzamine—CALM2—adipose tissue—Graves' disease	0.0108	0.0369	CbGeAlD
Phenoxybenzamine—CALM1—pituitary gland—Graves' disease	0.0108	0.0369	CbGeAlD
Phenoxybenzamine—CALM1—adipose tissue—Graves' disease	0.0107	0.0368	CbGeAlD
Phenoxybenzamine—ADRA1A—adipose tissue—Graves' disease	0.0101	0.0346	CbGeAlD
Phenoxybenzamine—ADRA2A—connective tissue—Graves' disease	0.01	0.0343	CbGeAlD
Phenoxybenzamine—ADRA2C—pituitary gland—Graves' disease	0.00965	0.0331	CbGeAlD
Phenoxybenzamine—ADRA2C—adipose tissue—Graves' disease	0.00961	0.033	CbGeAlD
Phenoxybenzamine—CALM2—thyroid gland—Graves' disease	0.00931	0.032	CbGeAlD
Phenoxybenzamine—CALM1—thyroid gland—Graves' disease	0.00927	0.0318	CbGeAlD
Phenoxybenzamine—ADRA2A—pituitary gland—Graves' disease	0.0077	0.0265	CbGeAlD
Phenoxybenzamine—ADRA2A—adipose tissue—Graves' disease	0.00767	0.0263	CbGeAlD
Phenoxybenzamine—ADRA2A—thyroid gland—Graves' disease	0.00664	0.0228	CbGeAlD
Phenoxybenzamine—ADRA2C—G alpha (i) signalling events—CXCL10—Graves' disease	0.00221	0.00312	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00221	0.00312	CbGpPWpGaD
Phenoxybenzamine—CALM2—Downstream signaling in naïve CD8+ T cells—IFNG—Graves' disease	0.00221	0.00312	CbGpPWpGaD
Phenoxybenzamine—CALM1—Downstream signaling in naïve CD8+ T cells—IFNG—Graves' disease	0.00221	0.00312	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—TSHR—Graves' disease	0.00219	0.00309	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00209	0.00294	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—TSHR—Graves' disease	0.00207	0.00293	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—TSHR—Graves' disease	0.00204	0.00288	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—GC—Graves' disease	0.00196	0.00277	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.0019	0.00268	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00188	0.00266	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00186	0.00262	CbGpPWpGaD
Phenoxybenzamine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.00185	0.0026	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—TSHR—Graves' disease	0.00181	0.00256	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	0.0018	0.00254	CbGpPWpGaD
Phenoxybenzamine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.00179	0.00252	CbGpPWpGaD
Phenoxybenzamine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	0.00179	0.00252	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.00178	0.00251	CbGpPWpGaD
Phenoxybenzamine—CALM3—Alzheimers Disease—IL1B—Graves' disease	0.00176	0.00249	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00176	0.00248	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00173	0.00244	CbGpPWpGaD
Phenoxybenzamine—CALM2—Alzheimers Disease—IL1B—Graves' disease	0.00171	0.00241	CbGpPWpGaD
Phenoxybenzamine—CALM1—Alzheimers Disease—IL1B—Graves' disease	0.00171	0.00241	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	0.00168	0.00238	CbGpPWpGaD
Phenoxybenzamine—CALM3—DAP12 interactions—HLA-B—Graves' disease	0.00168	0.00237	CbGpPWpGaD
Phenoxybenzamine—CALM2—Cardiac Hypertrophic Response—TNF—Graves' disease	0.00165	0.00233	CbGpPWpGaD
Phenoxybenzamine—CALM1—Cardiac Hypertrophic Response—TNF—Graves' disease	0.00165	0.00233	CbGpPWpGaD
Phenoxybenzamine—CALM2—DAP12 interactions—HLA-B—Graves' disease	0.00162	0.00229	CbGpPWpGaD
Phenoxybenzamine—CALM1—DAP12 interactions—HLA-B—Graves' disease	0.00162	0.00229	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR ligand binding—CXCL10—Graves' disease	0.00159	0.00224	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00154	0.00217	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—B3GNT2—Graves' disease	0.00149	0.0021	CbGpPWpGaD
Phenoxybenzamine—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.00148	0.00209	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.00144	0.00204	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR ligand binding—CXCL10—Graves' disease	0.00143	0.00202	CbGpPWpGaD
Phenoxybenzamine—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.00143	0.00202	CbGpPWpGaD
Phenoxybenzamine—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	0.00143	0.00202	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00143	0.00202	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—CXCL10—Graves' disease	0.00142	0.002	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—TSHR—Graves' disease	0.00139	0.00196	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—CXCL10—Graves' disease	0.00134	0.00189	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—CXCL10—Graves' disease	0.00132	0.00186	CbGpPWpGaD
Phenoxybenzamine—CALM3—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.00132	0.00186	CbGpPWpGaD
Phenoxybenzamine—CALM3—Alzheimers Disease—TNF—Graves' disease	0.00128	0.00181	CbGpPWpGaD
Phenoxybenzamine—CALM2—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.00127	0.0018	CbGpPWpGaD
Phenoxybenzamine—CALM1—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.00127	0.0018	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—TSHR—Graves' disease	0.00126	0.00178	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—TSHR—Graves' disease	0.00125	0.00177	CbGpPWpGaD
Phenoxybenzamine—CALM2—Alzheimers Disease—TNF—Graves' disease	0.00124	0.00175	CbGpPWpGaD
Phenoxybenzamine—CALM1—Alzheimers Disease—TNF—Graves' disease	0.00124	0.00175	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—TSHR—Graves' disease	0.00124	0.00175	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—GC—Graves' disease	0.00123	0.00174	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—GC—Graves' disease	0.0012	0.00169	CbGpPWpGaD
Phenoxybenzamine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.00118	0.00166	CbGpPWpGaD
Phenoxybenzamine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.00118	0.00166	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—TSHR—Graves' disease	0.00117	0.00165	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	0.00117	0.00165	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—IFIH1—Graves' disease	0.00116	0.00164	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—TSHR—Graves' disease	0.00115	0.00163	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—GC—Graves' disease	0.00115	0.00162	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—TSHR—Graves' disease	0.00114	0.00161	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IFIH1—Graves' disease	0.00113	0.00159	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IFIH1—Graves' disease	0.00113	0.00159	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—TSHR—Graves' disease	0.00112	0.00159	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	0.00109	0.00154	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—TSHR—Graves' disease	0.00106	0.0015	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—TSHR—Graves' disease	0.00105	0.00148	CbGpPWpGaD
Phenoxybenzamine—CALM3—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	0.00103	0.00145	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	0.00102	0.00145	CbGpPWpGaD
Phenoxybenzamine—CALM2—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	0.000995	0.0014	CbGpPWpGaD
Phenoxybenzamine—CALM1—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	0.000995	0.0014	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—IL2RA—Graves' disease	0.00098	0.00138	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—GC—Graves' disease	0.000972	0.00137	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	0.000952	0.00134	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—B3GNT2—Graves' disease	0.000933	0.00132	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	0.00093	0.00131	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—IL2RA—Graves' disease	0.000916	0.00129	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—HLA-E—Graves' disease	0.000915	0.00129	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—B3GNT2—Graves' disease	0.000907	0.00128	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—CXCL10—Graves' disease	0.000898	0.00127	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—GC—Graves' disease	0.000887	0.00125	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—HLA-E—Graves' disease	0.000885	0.00125	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—HLA-E—Graves' disease	0.000885	0.00125	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HLA-E—Graves' disease	0.000879	0.00124	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—B3GNT2—Graves' disease	0.000869	0.00123	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	0.000864	0.00122	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CD40—Graves' disease	0.000859	0.00121	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—GC—Graves' disease	0.000858	0.00121	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—GC—Graves' disease	0.000858	0.00121	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HLA-E—Graves' disease	0.00085	0.0012	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HLA-E—Graves' disease	0.00085	0.0012	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CTLA4—Graves' disease	0.000846	0.00119	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CD40—Graves' disease	0.000831	0.00117	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CD40—Graves' disease	0.000831	0.00117	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CTLA4—Graves' disease	0.000819	0.00116	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CTLA4—Graves' disease	0.000819	0.00116	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—CXCL10—Graves' disease	0.000815	0.00115	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—CXCL10—Graves' disease	0.000811	0.00114	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—B3GNT2—Graves' disease	0.000803	0.00113	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—CXCL10—Graves' disease	0.0008	0.00113	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—TSHR—Graves' disease	0.000789	0.00111	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—B3GNT2—Graves' disease	0.000777	0.0011	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—B3GNT2—Graves' disease	0.000777	0.0011	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—TSHR—Graves' disease	0.000763	0.00108	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—TSHR—Graves' disease	0.000763	0.00108	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—CXCL10—Graves' disease	0.000757	0.00107	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TSHR—Graves' disease	0.000745	0.00105	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000745	0.00105	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—IL2RA—Graves' disease	0.000744	0.00105	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—B3GNT2—Graves' disease	0.000737	0.00104	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—CXCL10—Graves' disease	0.000736	0.00104	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—CXCL10—Graves' disease	0.000727	0.00103	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000697	0.000983	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—CXCL10—Graves' disease	0.000688	0.00097	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—IL2RA—Graves' disease	0.000686	0.000968	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—IL2RA—Graves' disease	0.000679	0.000958	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IFIH1—Graves' disease	0.000677	0.000956	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—CXCL10—Graves' disease	0.000677	0.000955	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000674	0.000951	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000674	0.000951	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TSHR—Graves' disease	0.000673	0.000949	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—B3GNT2—Graves' disease	0.000672	0.000949	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TSHR—Graves' disease	0.000664	0.000937	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	0.000662	0.000934	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—IL2RA—Graves' disease	0.000657	0.000926	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—IL2RA—Graves' disease	0.000657	0.000926	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IFIH1—Graves' disease	0.000655	0.000925	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IFIH1—Graves' disease	0.000655	0.000925	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—HLA-B—Graves' disease	0.000652	0.00092	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CD8A—Graves' disease	0.000651	0.000918	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—B3GNT2—Graves' disease	0.00065	0.000918	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—B3GNT2—Graves' disease	0.00065	0.000918	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—HLA-B—Graves' disease	0.000631	0.00089	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—HLA-B—Graves' disease	0.000631	0.00089	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CD8A—Graves' disease	0.00063	0.000888	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CD8A—Graves' disease	0.00063	0.000888	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TSHR—Graves' disease	0.000629	0.000887	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HLA-B—Graves' disease	0.000626	0.000883	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL2RA—Graves' disease	0.000623	0.000879	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—IL2RA—Graves' disease	0.00062	0.000874	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TSHR—Graves' disease	0.000619	0.000873	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	0.000615	0.000868	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—IL2RA—Graves' disease	0.000612	0.000863	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HLA-B—Graves' disease	0.000606	0.000855	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HLA-B—Graves' disease	0.000606	0.000855	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	0.000601	0.000848	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HLA-A—Graves' disease	0.00058	0.000818	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—IL2RA—Graves' disease	0.000579	0.000816	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—IL2RA—Graves' disease	0.00057	0.000804	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL2RA—Graves' disease	0.000563	0.000794	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HLA-A—Graves' disease	0.000561	0.000792	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HLA-A—Graves' disease	0.000561	0.000792	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	0.000559	0.000788	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL2RA—Graves' disease	0.000555	0.000784	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TSHR—Graves' disease	0.00055	0.000775	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-E—Graves' disease	0.000533	0.000752	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HLA-DRB1—Graves' disease	0.00053	0.000748	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL2RA—Graves' disease	0.000526	0.000741	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD40—Graves' disease	0.000521	0.000735	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL2RA—Graves' disease	0.000517	0.00073	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-E—Graves' disease	0.000516	0.000727	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-E—Graves' disease	0.000516	0.000727	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CTLA4—Graves' disease	0.000513	0.000724	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000513	0.000723	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000513	0.000723	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TSHR—Graves' disease	0.000511	0.00072	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—CXCL10—Graves' disease	0.00051	0.000719	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—ICAM1—Graves' disease	0.000509	0.000718	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	0.000506	0.000714	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD40—Graves' disease	0.000504	0.000711	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD40—Graves' disease	0.000504	0.000711	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CTLA4—Graves' disease	0.000497	0.000701	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CTLA4—Graves' disease	0.000497	0.000701	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CXCL10—Graves' disease	0.000493	0.000695	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CXCL10—Graves' disease	0.000493	0.000695	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—ICAM1—Graves' disease	0.000492	0.000694	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—ICAM1—Graves' disease	0.000492	0.000694	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CXCL10—Graves' disease	0.000482	0.00068	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	0.00047	0.000663	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TSHR—Graves' disease	0.000466	0.000657	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	0.000459	0.000648	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TSHR—Graves' disease	0.000451	0.000636	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TSHR—Graves' disease	0.000451	0.000636	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CXCL10—Graves' disease	0.000435	0.000613	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CXCL10—Graves' disease	0.000429	0.000606	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	0.000427	0.000602	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-DQB1—Graves' disease	0.000423	0.000596	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GC—Graves' disease	0.000414	0.000584	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-DQB1—Graves' disease	0.000409	0.000577	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-DQB1—Graves' disease	0.000409	0.000577	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CXCL10—Graves' disease	0.000406	0.000573	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CXCL10—Graves' disease	0.0004	0.000564	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD8A—Graves' disease	0.000395	0.000557	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL2RA—Graves' disease	0.000389	0.00055	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—CD4—Graves' disease	0.000389	0.000549	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD8A—Graves' disease	0.000382	0.000539	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD8A—Graves' disease	0.000382	0.000539	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-B—Graves' disease	0.00038	0.000536	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL2RA—Graves' disease	0.000377	0.000532	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL2RA—Graves' disease	0.000377	0.000532	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—CD4—Graves' disease	0.000377	0.000531	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—CD4—Graves' disease	0.000377	0.000531	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CD4—Graves' disease	0.000374	0.000527	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL2RA—Graves' disease	0.000368	0.000519	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-B—Graves' disease	0.000367	0.000518	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-B—Graves' disease	0.000367	0.000518	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CD4—Graves' disease	0.000362	0.00051	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CD4—Graves' disease	0.000362	0.00051	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL2RA—Graves' disease	0.000356	0.000502	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	0.000355	0.000501	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-A—Graves' disease	0.000352	0.000496	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL2RA—Graves' disease	0.000344	0.000486	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL2RA—Graves' disease	0.000344	0.000486	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-A—Graves' disease	0.00034	0.00048	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-A—Graves' disease	0.00034	0.00048	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL2RA—Graves' disease	0.000332	0.000469	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	0.00033	0.000465	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL2RA—Graves' disease	0.000328	0.000463	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HLA-A—Graves' disease	0.000325	0.000458	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-DRB1—Graves' disease	0.000321	0.000454	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HLA-A—Graves' disease	0.000314	0.000443	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HLA-A—Graves' disease	0.000314	0.000443	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—B3GNT2—Graves' disease	0.000314	0.000443	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-DRB1—Graves' disease	0.000311	0.000439	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-DRB1—Graves' disease	0.000311	0.000439	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL2RA—Graves' disease	0.00031	0.000438	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—ICAM1—Graves' disease	0.000309	0.000435	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL2RA—Graves' disease	0.000306	0.000431	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCL10—Graves' disease	0.000301	0.000425	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—ICAM1—Graves' disease	0.000298	0.000421	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—ICAM1—Graves' disease	0.000298	0.000421	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL10—Graves' disease	0.000291	0.000411	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL10—Graves' disease	0.000291	0.000411	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	0.000271	0.000383	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	0.000252	0.000356	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IFNG—Graves' disease	0.000235	0.000331	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL2RA—Graves' disease	0.00023	0.000325	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IFNG—Graves' disease	0.000227	0.00032	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IFNG—Graves' disease	0.000227	0.00032	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD4—Graves' disease	0.000227	0.00032	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL2RA—Graves' disease	0.000223	0.000314	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL2RA—Graves' disease	0.000223	0.000314	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD4—Graves' disease	0.000219	0.000309	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD4—Graves' disease	0.000219	0.000309	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL1B—Graves' disease	0.000209	0.000295	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CD4—Graves' disease	0.000209	0.000295	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL1B—Graves' disease	0.000203	0.000286	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL1B—Graves' disease	0.000203	0.000286	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CD4—Graves' disease	0.000203	0.000286	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CD4—Graves' disease	0.000203	0.000286	CbGpPWpGaD
